Intel announces a special collaboration with Lawrence Livermore National Laboratory (LLNL), which will use Intel Xeon Scalable processors in one of its high-performance computing clusters.
Ruby is a new high-performance computing cluster by Lawrence Livermore National Laboratory (LLNL) , to be used for the research of therapeutic drugs and antibodies against SARS-CoV-2, that is, COVID-19 , how much havoc it is causing around the world.
Intel, LLNL, Supermicro and Cornelis Networks were involved in the construction of Ruby . The team uses 1,500 nodes with Intel Xeon Scalable processors and 192GB of RAM. The estimate tells us that Ruby is going to deliver a calculation power of 6 petaflops at most, so we would be talking about one of the 100 most powerful supercomputers in the world.
Ruby’s development was driven, to a greater extent, to find a cure for COVID-19 and help create a vaccine.
“Our long association with Lawrence Livermore National Laboratory continues to drive tremendous advancements in scientific research and discovery in a wide range of applications,” said Trish Damkroger, who is the vice president and general manager of high-performance computing at Intel. “We are excited to see that the Ruby supercomputer is now contributing to COVID-19 research.”
The Ruby supercomputer is going to have a lot of additional applications, in addition to pharmaceutical applications, such as asteroid detection, moon formation, high-fidelity fission, plasma dynamics, etc, etc, which are of vital importance within the scientific field.
Another of the actors involved in this project is the NNSA Advanced Simulation and Computing, the Laboratory’s Multi-programmatic and Institutional Computing, and the Coronavirus Aid, Relief, and Economic Security Act.
Current Xeon Scalable processors offer up to 28 cores and 56 threads clocked at 4.3 GHz. We’ll keep you posted.